PHASE-I-II STUDY OF EFLORNITHINE AND MITOGUAZONE COMBINED IN THE TREATMENT OF RECURRENT PRIMARY BRAIN-TUMORS
- 1 May 1987
- journal article
- research article
- Vol. 71 (5) , 459-464
Abstract
Eflornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, and mitoguazone (MGBG), a competitive inhibitor of S-adenosylmethionine decarboxylase, were evaluated in a phase I-II study for patients with primary recurrent malignant brain tumors. All patients had failed prior radiation therapy and most had also failed prior chemotherapy. Two dose schedules were used, with the second schedule (Group II) a modification of the first schedule (Group I). The Group II schedule, with different dose levels, was better tolerated than the Group I schedule. Gastrointestinal and myelotoxicity were dose-limiting in most patients, and tinnitus was dose-limiting in two patients. Nineteen of 33 evaluable patients had anaplastic gliomas, in whom response was observed in 21%, stable disease in 53%, and immediate progression after one course of theraphy in 26%. Of six patients with glioblastoma multiforme, two had brief stabilization of disease. An additional patient with brainstem glioma and ependymoma also had disease stabilization. Four patients with medulloblastoma, a spinal cord mixed glioma, and one with oligodendroglioma failed DFMO-MGBG. Based on this study, we believe that a combination of DFMO and MGBG is well-tolerated and deserves further evaluation for patients with anaplastic gliomas, particularly those that appear to be biologically slow growing.This publication has 24 references indexed in Scilit:
- PENETRATION OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE) INTO INTRA-CEREBRAL TUMORS IN HUMANS1981
- Depletion of 9L rat brain tumor cell polyamine content by treatment with -?-difluoromethylornithine inhibits proliferation and the G1 to S transitionExperimental Cell Research, 1981
- Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone)Biochemical Journal, 1980
- Quantitation of methylglyoxal bis(guanylhydrazone) in blood plasma and leukemia cells of patients receiving the drugInternational Journal of Cancer, 1980
- MODIFIED PROCARBAZINE, CCNU, AND VINCRISTINE (PCV-3) COMBINATION CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT BRAIN-TUMORS1980
- GENERALITY OF METHYLGLYOXAL BIS-(GUANYLHYDRAZONE)-INDUCED MITOCHONDRIAL DAMAGE AND THE DEPENDENCE OF THIS EFFECT ON CELL-PROLIFERATION1979
- EFFECT OF ALPHA-DIFLUOROMETHYLORNITHINE, AN ENZYME-ACTIVATED IRREVERSIBLE INHIBITOR OF ORNITHINE DECARBOXYLASE, ON L1210 LEUKEMIA IN MICE1978
- Criteria for evaluating patients undergoing chemotherapy for malignant brain tumorsJournal of Neurosurgery, 1977
- DNA Synthesis in HeLa Cells and Isolated Nuclei after Treatment with an Inhibitor of Spermidine Synthesis, Methyl Glyoxal Bis(guanylhydrazone)European Journal of Biochemistry, 1977
- INHIBITION OF SYNTHESIS OF POLYAMINES AND DNA IN ACTIVATED LYMPHOCYTES BY A COMBINATION OF ALPHA-METHYLORNITHINE AND METHYLGLYOXAL BIS(GUANYLHYDRAZONE)1977